Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

Loprax 5 Ch Drops ; Globules ; Granules is a Health Canada–registered human drug (DIN 02234195) held by Homeocan Inc., containing Poison Ivy. Health Canada lists its status as Cancelled Post Market (status date 29 Apr 2010). Nexara Health has matched 3 registrations of Poison Ivy across 1 other regulated market, 1 of them in the same strength and dosage form.

Health Canada registration

DIN02234195
Brand nameLoprax
Active ingredientPoison Ivy
Strength5 Ch
Dosage formDrops ; Globules ; Granules
RouteOral
CompanyHomeocan Inc.
StatusCancelled Post Market — 29 Apr 2010
ClassHuman
ATC
AHFS
Regulator recordHealth Canada DPD entry · Product monograph

Poison Ivy registered in other markets

3 registrations of the same molecule in 1 national registry outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.

CountryProductMarketing authorisation holderStrengthFormStatusRegistry
United StatesPoison Ivy/Oak 1013Professional Complementary Health FormulasLiquidlistedFDA NDC
United StatesPoison Ivy and OakMarie's Original Formulas LLCSoaplistedFDA NDC
United StatesPoison Ivy and OakMarie's Original Formulas LLCSoaplistedFDA NDC

See every manufacturer of Poison Ivy worldwide →

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Loprax (DIN 02234195) marketed in Canada?

No. Health Canada lists DIN 02234195 as Cancelled Post Market as of 29 Apr 2010.

Who holds the Canadian licence for this product?

Homeocan Inc. is the company of record in the Health Canada Drug Product Database.

Is Poison Ivy registered outside Canada?

Yes — Nexara Health has matched 3 registrations in 1 other market, including 1 in the same strength and dosage form (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 02234195, status date 2010-04-29; national medicine registries: FDA NDC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 02234195, status date 2010-04-29; national medicine registries: FDA NDC.

Health Canada Drug Product Database (DPD), DIN 02234195, status date 2010-04-29; national medicine registries: FDA NDC. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.